HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery (Q39084265)

8 September 2017

HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery (English)

1 reference

8 September 2017

0 references

3

1 reference

8 September 2017

Abdulaziz Almalik

1

1 reference

PubMed ID

24106105

8 September 2017

Philip J Day

series ordinal

2

1 reference

8 September 2017

17 September 2013

1 reference

Macromolecular Bioscience

8 September 2017

1 reference

8 September 2017

13

1 reference

8 September 2017

12

1 reference

8 September 2017

1671-1680

1 reference

The promises and pitfalls of RNA-interference-based therapeutics

8 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Silencing human genetic diseases with oligonucleotide-based therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Therapeutic and prophylactic DNA vaccines for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Gene therapy for autoimmune diseases: quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Intravenous, non-viral RNAi gene therapy of brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Towards safe, non-viral therapeutic gene expression in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Gene delivery by lipoplexes and polyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Toxicity of cationic lipids and cationic polymers in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Biological barriers to therapy with antisense and siRNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Chitosan-based formulations for delivery of DNA and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Glycosylation of CD44 negatively regulates its recognition of hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Nanostructured hyaluronic acid-based materials for active delivery to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

CD44: a validated target for improved delivery of cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Macrophages and fibroblasts during inflammation, tissue damage and organ injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

CD44 is a phagocytic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

The transmembrane domains of L-selectin and CD44 regulate receptor cell surface positioning and leukocyte adhesion under flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Expression of CD44 is repressed in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Water-soluble and low molecular weight chitosan-based plasmid DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300302

21 January 2018

Identifiers

DOI

10.1002/MABI.201300302

1 reference

8 September 2017

1 reference

PubMed ID

24106105